Reaction profile

The FDA adverse-event record for application site pigmentation disorders

20 FDA reports name application site pigmentation disorders, a lower-volume reaction in the CVM extract (VeDDRA 2517). Plate stamps and neighbourhood peers follow.

#2156 of 2,481
by report volume (all reactions)
20
reports citing this reaction
0.0%
death-coded share
Cat
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Application site pigmentation disorders has 20 reports now versus 20 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Application site pigmentation disorders changes

FDA AER · VeDDRA plate

Code 2517 VOL-TRACE

VOL-TRACE · DEATH-RARE · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 20 reports
  • DEATH-RARE 0.0%
  • LOWER-Q #2156/2481
  • PHOTO-FINISH Agalactia
  • SPECIES-CAT Cat · 11
  • DRUG-LEAD Prednisone · 6
  • DESK-WIDE 14 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Agalactia (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Application site pigmentation disorders

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Agalactia · near20Application site pigm… · thi…20Application site skin… · near20Cirrhosis · near20Clonic muscle spasm · near20Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Application site pigmentation disorders

Application site pigmentation disorders: low death-coded share in the FDA AER plate

Signature read: Application site pigmentation disorders's 0.0% death-coded share is among the lowest in the openFDA reaction corpus. Report volume is lower-third scale: 20 named reports in the openFDA extract. Death-coded share is lower-third: 0 of 20 reports (0.0% of named reports). Nearest volume peer: Agalactia (±0 reports). Lead species Cat (11). Lead co-reported drug Prednisone (6).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Prednisone appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 11
Dog 9

Breeds Most Affected

Domestic Shorthair 5
Retriever - Labrador 2
Siamese 2
Shih Tzu 1
Boxer (German Boxer) 1
Domestic Longhair 1
Sheepdog - Shetland 1
Bengal 1
Samoyed 1
Great Pyrenees 1

Associated Drugs

Prednisone 6
Mirtazapine 3
Selamectin;Sarolaner 3
Diphenhydramine 3
Famotidine 3
Selamectin 2
Imidacloprid + Moxidectin 2
Eprinomectin + Praziquantel 2
Gabapentin 2
Isoflurane 2
Oxygen 2
Carprofen 1
Chlorambucil 1
Furosemide 1
Sotalol Hcl 1
Enalapril Maleate 1
S-Adenosylmethionine/Silybin 1
Bupivacaine Lipsome Injectable Suspension 1
Dexamethasone + Neomycin Sulfate + Thiabendazole 1
Cyclosporin Ointment 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Application site pigmentation disorders (#2156 of 2,481 by report volume); death-coded 0.0%. PlainBreed reaction plate · death-coded share stamp 0.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →